Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor γ

Molecular and Cellular Biology

Volumn 27, Issue 3, 2007, Pages 803-817

  Burgermeister, Elke ^a,c   Chuderland, Dana ^a   Hanoch, Tamar ^a   Meyer, Markus ^b   Liscovitch, Mordechai ^a   Seger, Rony ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CELL NUCLEUS RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PEPTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHORBOL 13 ACETATE 12 MYRISTATE; SERINE; SMALL INTERFERING RNA;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE MUTATION; GENE REPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT GENE; MITOGENESIS; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ACYL-COA OXIDASE; ANIMALS; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; CRICETULUS; CYTOSOL; DOWN-REGULATION; HELA CELLS; HUMANS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 3; PPAR GAMMA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RATS; SERINE; TETRADECANOYLPHORBOL ACETATE; THIAZOLIDINEDIONES; TRANS-ACTIVATION (GENETICS); TWO-HYBRID SYSTEM TECHNIQUES;

EID: 33846590071     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00601-06     Document Type: Article

References (47)

1. Adachi, M., M. Fukuda, and E. Nishida. 2000. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J. Cell Biol. 148:849-856. (Erratum, 149:754.)
2. Adams, M., M. J. Reginato, D. Shao, M. A. Lazar, and V. K. Chatterjee. 1997. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272:5128-5132.
3. Aebersold, D. M., Y. D. Shaul, Y. Yung, N. Yarom, Z. Yao, T. Hanoch, and R. Seger. 2004. Extracellular signal-regulated kinase 1c (ERK1c), a novel 42-kilodalton ERK, demonstrates unique modes of regulation, localization, and function. Mol. Cell. Biol. 24:10000-10015.
4. Akaike, M., W. Che, N. L. Marmarosh, S. Ohta, M. Osawa, B. Ding, B. C. Berk, C. Yan, and J. Abe. 2004. The hinge-helix 1 region of peroxisome proliferator-activated receptor γ1 (PPARγ1) mediates interaction with extracellular signal-regulated kinase 5 and PPARγ1 transcriptional activation: involvement in flow-induced PPARγ activation in endothelial cells. Mol. Cell. Biol. 24:8691-8704.
5. Akiyama, T. E., C. T. Baumann, S. Sakai, G. L. Hager, and F. J. Gonzalez. 2002. Selective intranuclear redistribution of PPAR isoforms by RXR alpha. Mol. Endocrinol. 16:707-721.
6. Berger, J., H. V. Patel, J. Woods, N. S. Hayes, S. A. Parent, J. Clemas, M. D. Leibowitz, A. Elbrecht, R. A. Rachubinski, J. P. Capone, and D. E. Moller. 2000. A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus. Mol. Cell. Endocrinol. 162:57-67.
7. Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
8. Bruna, A., M. Nicolas, A. Munoz, J. M. Kyriakis, and C. Caelles. 2003. Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J. 22:6035-6044.
9. Burgermeister, E., M. Lanzendoerfer, and W. Scheuer. 2003. Comparative analysis of docking motifs in MAP-kinases and nuclear receptors. J. Biomol. Struct. Dyn. 20:623-634.
10. Burgermeister, E., L. Tencer, and M. Liscovitch. 2003. Peroxisome proliferator-activated receptor-γ upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. Oncogene 22:3888-3900.
11. Camp, H. S., S. R. Tafuri, and T. Leff. 1999. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gammal and negatively regulates its transcriptional activity. Endocrinology 140:392-397.
12. Chen, D., T. Riedl, E. Washbrook, P. E. Pace, R. C. Coombes, J. M. Egly, and S. Ali. 2000. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell 6:127-137.
13. Chen, F., M. Wang, J. P. O'Connor, M. He, T. Tripathi, and L. E. Harrison. 2003. Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta. J. Cell. Biochem. 90:732-744.
14. Diradourian, C., J. Girard, and J. P. Pegorier. 2005. Phosphorylation of PPARs: from molecular characterization to physiological relevance. Biochimie 87:33-38.
15. Duesbery, N. S., C. P. Webb, S. H. Leppla, V. M. Gordon, K. R. Klimpel, T. D. Copeland, N. G. Ahn, M. K. Oskarsson, K. Fukasawa, K. D. Paull, and G. F. Vande Woude. 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280:734-737.
16. Fields, S., and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 340:245-246.
17. Floyd, Z. E., and J. M. Stephens. 2002. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J. Biol. Chem. 277:4062-4068.
18. Fukuda, M., I. Gotoh, M. Adachi, Y. Gotoh, and E. Nishida. 1997. A novel regulatory mechanism in the mitogen-activated protein (MAP) kinase cascade. Role of nuclear export signal of MAP kinase kinase. J. Biol. Chem. 272:32642-32648.
19. Gardner, O. S., B. J. Dewar, H. S. Earp, J. M. Samet, and L. M. Graves. 2003. Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation. J. Biol. Chem. 278:46261-46269.
20. Gurnell, M., J. M. Wentworth, M. Agostini, M. Adams, T. N. Collingwood, C. Provenzano, P. O. Browne, O. Rajanayagam, T. P. Burris, J. W. Schwabe, M. A. Lazar, and V. K. Chatterjee. 2000. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J. Biol. Chem. 275:5754-5759.
21. Ho, A., S. R. Schwarze, S. J. Mermelstein, G. Waksman, and S. F. Dowdy. 2001. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61:474-477.
22. Hu, E., J. B. Kim, P. Sarraf, and B. M. Spiegelman. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR-gamma. Science 274:2100-2103.
23. Jaaro, H., H. Rubinfeld, T. Hanoch, and R. Seger. 1997. Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation. Proc. Natl. Acad. Sci. USA 94:3742-3747.
24. Kyriakis, J. M. 2000. MAP kinases and the regulation of nuclear receptors. Sci. STKE 2000:PE1.
25. Lenormand, P., C. Sardet, G. Pages, G. L'Allemain, A. Brunet, and J. Pouyssegur. 1993. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol. 122:1079-1088.
26. Lu, M. L., M. C. Schneider, Y. Zheng, X. Zhang, and J. P. Richie. 2001. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J. Biol. Chem. 276:13442- 13451.
27. Marenda, D. R., A. D. Vrailas, A. B. Rodrigues, S. Cook, M. A. Powers, J. A. Lorenzen, L. A. Perkins, and K. Moses. 2006. MAP kinase subcellular localization controls both pattern and proliferation in the developing Drosophila wing. Development 133:43-51.
28. Perry, R. L., M. H. Parker, and M. A. Rudnicki. 2001. Activated MEKl binds the nuclear MyoD transcriptional complex to repress transactivation. Mol. Cell 8:291-301.
29. Raviv, Z., E. Kalie, and R. Seger. 2004. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation. J. Cell Sci. 117:1773-1784.
30. Reginato, M. J., S. L. Krakow, S. T. Bailey, and M. A. Lazar. 1998. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 273:1855-1858.
31. Rosen, E. D., and B. M. Spiegelman. 2001. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276:37731-37734.
32. Rubinfeld, H., T. Hanoch, and R. Seger. 1999. Identification of a cytoplasmic-retention sequence in ERK2. J. Biol. Chem. 274:30349-30352.
33. Sato, H., S. Ishihara, K. Kawashima, N. Moriyama, H. Suetsugu, H. Kazumori, T. Okuyama, M. A. Rumi, R. Fukuda, N. Nagasue, and Y. Kinoshita. 2000. Expression of peroxisome proliferator-activated receptor (PPAR) gamma in gastric cancer and inhibitory effects of PPARgamma agonists. Br. J. Cancer 83:1394-1400.
34. Schlegel, A., C. Wang, B. S. Katzenellenbogen, R. G. Pestell, and M. P. Lisanti. 1999. Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling, caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha. J. Biol. Chem. 274:33551-33556.
35. Shibuya, A., K. Wada, A. Nakajima, M. Saeki, K. Katayama, T. Mayumi, T. Kadowaki, H. Niwa, and Y. Kamisaki. 2002. Nitration of PPARgamma inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line, RAW 264. FEBS Lett. 525:43-47.
36. Sumanasekera, W. K., E. S. Tien, J. W. Davis II, R. Turpey, G. H. Perdew, and J. P. Vanden Heuvel. 2003. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity. Biochemistry 42:10726-10735.
37. Takeda, K., T. Ichiki, T. Tokunou, N. Iino, and A. Takeshita. 2001. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. J. Biol. Chem. 276:48950-48955.
38. Tanoue, T., M. Adachi, T. Moriguchi, and E. Nishida. 2000. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat. Cell Biol. 2:110-116.
39. Thuillier, P., R. Baillie, X. Sha, and S. D. Clarke. 1998. Cytosolic and nuclear distribution of PPARgamma2 in differentiating 3T3-L1 preadipocytes. J. Lipid Res. 39:2329-2338.
40. Tolwinski, N. S., P. S. Shapiro, S. Goueli, and N. G. Ahn. 1999. Nuclear localization of mitogen-activated protein kinase kinase 1 (MKK1) is promoted by serum stimulation and G2-M progression. Requirement for phosphorylation at the activation lip and signaling downstream of MKK. J. Biol. Chem. 274:6168-6174.
41. Tugwood, J. D., I. Issemann, R. G. Anderson, K. R. Bundell, W. L. McPheat, and S. Green. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11:433-439.
42. Varley, C. L., J. Stahlschmidt, W. C. Lee, J. Holder, C. Diggle, P. J. Selby, L. K. Trejdosiewicz, and J. Southgate. 2004. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme. J. Cell Sci. 117:2029-2036.
43. Wolf, I., H. Rubinfeld, S. Yoon, G. Marmor, T. Hanoch, and R. Seger. 2001. Involvement of the activation loop of ERK in the detachment from cytosolic anchoring. J. Biol. Chetn. 276:24490-24497.
44. Xu, B. E., S. Stippec, F. Robinson, and M. H. Cobb. 2001. Hydrophobic as well as charged residues in both MEK1 and ERK2 are important for their proper docking. J. Biol. Chem. 276:26509-26515.
45. Yao, Z., I. Flash, Z. Raviv, Y. Yung, Y. Asscher, S. Pleban, and R. Seger. 2001. Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1. Oncogene 20:7588-7596.
46. Yoon, S., and R. Seger. 2006. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21-44.
47. Yung, Y., Z. Yao, T. Hanoch, and R. Seger. 2000. ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK. J. Biol. Chem. 275:15799-15808.